In vitro andin vivo effects of ipriflavone on bone formation and bone biomechanics R. Civitelli Satellite Workshop Abstracts Pages: 317 - 317
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-Agonist M. GambaccianiB. CappagliA. R. Genazzani Satellite Workshop Abstracts Pages: 317 - 317
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass C. Gennan Satellite Workshop Abstracts Pages: 318 - 318
Effect of ipriflavone in established osteoporosis, and long-term safety D. Agnusdel Satellite Workshop Abstracts Pages: 318 - 318
Design for IMEFS (iprielavone multicentre european fracture study) J Y ReginsterCh. RouxB J Riis Satellite Workshop Abstracts Pages: 318 - 318